Comments
Loading...

Rani Therapeutics Hldgs

RANINASDAQ
Logo brought to you by Benzinga Data
$1.42
0.000.00%
At close: -
$1.44
0.021.41%
After Hours: 2:32 PM EDT
Consensus Rating1
Buy
Highest Price Target1
$17.00
Lowest Price Target1
$8.00
Consensus Price Target1
$12.67

Rani Therapeutics Hldgs (NASDAQ:RANI) Stock, Analyst Ratings, Price Targets, Forecasts

Rani Therapeutics Holdings Inc has a consensus price target of $12.67 based on the ratings of 9 analysts. The high is $17 issued by Oppenheimer on August 2, 2024. The low is $8 issued by Wedbush on February 6, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on November 19, 2024, October 18, 2024, and August 16, 2024, respectively. With an average price target of $9 between HC Wainwright & Co., there's an implied 525.00% upside for Rani Therapeutics Holdings Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Aug
1
Oct
1
Nov
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Oppenheimer
Maxim Group
Rodman & Renshaw
BTIG

1calculated from analyst ratings

Analyst Ratings for Rani Therapeutics Hldgs

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Rani Therapeutics Hldgs (RANI) stock?

A

The latest price target for Rani Therapeutics Hldgs (NASDAQ:RANI) was reported by HC Wainwright & Co. on November 19, 2024. The analyst firm set a price target for $9.00 expecting RANI to rise to within 12 months (a possible 525.00% upside). 12 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Rani Therapeutics Hldgs (RANI)?

A

The latest analyst rating for Rani Therapeutics Hldgs (NASDAQ:RANI) was provided by HC Wainwright & Co., and Rani Therapeutics Hldgs reiterated their buy rating.

Q

When was the last upgrade for Rani Therapeutics Hldgs (RANI)?

A

There is no last upgrade for Rani Therapeutics Hldgs

Q

When was the last downgrade for Rani Therapeutics Hldgs (RANI)?

A

There is no last downgrade for Rani Therapeutics Hldgs.

Q

When is the next analyst rating going to be posted or updated for Rani Therapeutics Hldgs (RANI)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Rani Therapeutics Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Rani Therapeutics Hldgs was filed on November 19, 2024 so you should expect the next rating to be made available sometime around November 19, 2025.

Q

Is the Analyst Rating Rani Therapeutics Hldgs (RANI) correct?

A

While ratings are subjective and will change, the latest Rani Therapeutics Hldgs (RANI) rating was a reiterated with a price target of $9.00 to $9.00. The current price Rani Therapeutics Hldgs (RANI) is trading at is $1.44, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch